BRIEF published on 11/18/2024 at 18:05, 2 days 19 hours ago SCBSM: Declaration of Transactions on Own Shares Euronext Paris Transactions Own Shares SCBSM Article 5 MAR
BRIEF published on 11/12/2024 at 18:05, 8 days 19 hours ago SCBSM: Declaration of transactions in own shares Euronext Paris Share Buyback Own Shares Market Abuse SCBSM
BRIEF published on 11/05/2024 at 18:05, 15 days 19 hours ago SCBSM Share Buyback Program: New Extension Euronext Paris Share Capital Share Buyback SCBSM Program
BRIEF published on 11/04/2024 at 18:05, 16 days 19 hours ago SCBSM Reports Its Own Share Transactions Euronext Paris Own Shares MAR Regulations Stock Market Transactions SCBSM
BRIEF published on 10/29/2024 at 18:05, 22 days 19 hours ago Provision of the 2023-2024 Universal Registration Document by SCBSM Euronext Paris Transparency Financial Markets Universal Registration Document SCBSM
BRIEF published on 10/29/2024 at 07:35, 23 days 6 hours ago SCBSM posts 20% increase in recurring profit in 2023-2024 ESG Rating Debt Reduction SCBSM Parisian Real Estate Recurring Profit
BRIEF published on 10/28/2024 at 18:05, 23 days 19 hours ago SCBSM: Statement on share buybacks Euronext Paris Share Buyback Financial Transparency SCBSM Article 5 MAR
BRIEF published on 10/21/2024 at 18:05, 30 days 19 hours ago SCBSM: Declaration of share buybacks Euronext Paris Share Buyback Own Shares XPAR Market SCBSM
BRIEF published on 10/14/2024 at 18:05, 1 month 6 days ago SCBSM: Declared own share transactions Euronext Paris Own Shares Redemption SCBSM Walk
BRIEF published on 10/07/2024 at 21:35, 1 month 13 days ago SCBSM reports its transactions on own shares Euronext Paris Share Buyback Own Shares XPAR Market SCBSM
Published on 11/21/2024 at 13:30, 23 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 23 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 53 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 53 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 53 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 18 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 8 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
